Carboxypeptidase-mediated regulation of endopeptidase activity in Vibrio cholerae
The bacterial cell wall, primarily composed of peptidoglycan (PG), is critical for maintaining cell shape and protecting against environmental stress and osmotic pressure. As bacteria grow, PG is continuously remodeled to accommodate expansion, a process mediated by enzymes known as autolysins. Endopeptidases (EPs), a type of autolysin, cleave crosslinks between PG strands, enabling the insertion of newly synthesized material. Despite being essential for bacterial growth, EP activity must be tightly regulated to prevent excessive PG degradation, which could compromise cell wall integrity. However, the regulatory mechanisms controlling EP activity are not well understood.The diarrheal pathogen, Vibrio cholerae encodes 9 endopeptidases. Among the 9 enzymes, only ShyA and ShyC are collectively essential for growth. This study focuses on ShyA, which exists in two forms: a closed, inactive conformation, and an open, active conformation. The factors involved in this conformational switch remain unknown, but activation is essential for proper function. In this work, we performed a Transposon Sequencing (TnSeq) screen to identify genes that modulate the activity of activated ShyA. We identified another autolysin, the carboxypeptidase DacA1 (PBP5) as a previously unknown factor that mitigates the toxicity of hyperactive ShyA. DacA1 acts on the same substrate as ShyA—the PG peptide side stem—by removing the fifth amino acid. Our data suggest that DacA1 modulates ShyA activity by producing its preferred substrate, tetrapeptide-containing crosslinks. Moreover, DacA1 is essential for growth, and its loss can be counteracted by either enhancing cell wall degradation or reducing PG synthesis, highlighting its role in balancing PG synthesis and degradation. We also describe a novel regulatory relationship between DacA1 and ShyA. Our research indicates that DacA1 influences ShyA activity not only by altering PG substrate but also through direct physical interaction. Genetic data suggests that DacA1 activates ShyA in vivo, a process that appears to be conserved in other Gram-negative bacteria. However, in vitro studies show an opposite effect, where DacA1 inhibits ShyA, likely because the specific PG structure required for this regulation is absent. Given that DacA1 localizes to regions of active PG synthesis, these findings propose a new model in which DacA1 helps to coordinate PG synthesis and degradation, enabling the expansion of the bacterial cell wall.